Insider · CIK 0001578771
Julie Hambleton
director
Files at IGMS (IGM Biosciences, Inc.), ERAS (Erasca, Inc.), SWTX (SpringWorks Therapeutics, Inc.). First filing Feb 12, 2025, latest Feb 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $730k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | SpringWorks Therapeutics, Inc. | $730k 13,774 shares | -77% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | DDisposition to issuer Common Stock | -2,000 | - | - | 0 | Aug 14, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Common Stock | -14,155 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -14,668 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,318 | - | - | 0 | Jul 2, 2025 |
| Jul 1, 2025 | SWTX SpringWorks Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,216 | - | - | 0 | Jul 2, 2025 |
| Jun 24, 2025 | ERAS Erasca, Inc. | AGrant or award Stock option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jun 26, 2025 |
| May 14, 2025 | SWTX SpringWorks Therapeutics, Inc. | AGrant or award Common Stock | +10,060 | $0.00 | $0 | 14,155 | May 15, 2025 |
| Feb 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +13,774 | $32.27 | $444k | 17,869 | Feb 12, 2025 |
| Feb 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -13,774 | $53.01 | $730k | 4,095 | Feb 12, 2025 |
| Feb 10, 2025 | SWTX SpringWorks Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,774 | $0.00 | $0 | 0 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.